X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (153) 153
humans (139) 139
pharmacology & pharmacy (136) 136
animals (96) 96
time-dependent inhibition (85) 85
male (75) 75
time factors (73) 73
pharmacokinetics (64) 64
rats (47) 47
drug interactions (46) 46
kinetics (44) 44
models, biological (42) 42
dose-response relationship, drug (36) 36
female (34) 34
in-vitro (33) 33
metabolism (33) 33
drug-drug interactions (32) 32
toxicology (32) 32
microsomes, liver - drug effects (29) 29
cytochrome p-450 enzyme system - metabolism (27) 27
chemistry, medicinal (26) 26
cytochrome p450 (26) 26
cytochrome p-450 (25) 25
biochemistry & molecular biology (24) 24
mechanism-based inactivation (24) 24
adult (22) 22
analysis (22) 22
drugs (22) 22
enzyme inhibitors - pharmacology (22) 22
human liver-microsomes (22) 22
enzymes (21) 21
microsomes, liver - metabolism (21) 21
inhibition (20) 20
neurosciences (20) 20
pharmacology (20) 20
cyp3a4 (19) 19
cytochrome p-450 cyp3a - metabolism (19) 19
metabolites (19) 19
middle aged (19) 19
pharmacology/toxicology (19) 19
time-dependent (19) 19
area under curve (18) 18
cytochrome p-450 enzyme inhibitors (18) 18
liver (18) 18
microsomes, liver - enzymology (18) 18
pharmacy (18) 18
prediction (18) 18
research (18) 18
aged (17) 17
mice (17) 17
time-dependent pharmacokinetics (17) 17
administration, oral (16) 16
biomedicine (16) 16
cancer (16) 16
cytochrome p-450 cyp3a inhibitors (16) 16
drug-drug interaction (16) 16
physiological aspects (16) 16
rats, sprague-dawley (16) 16
chemistry, organic (15) 15
cytochrome p-450 enzyme inhibitors - pharmacology (14) 14
mass spectrometry (14) 14
time dependence (14) 14
drug administration schedule (13) 13
oncology (13) 13
drug delivery systems (12) 12
half-life (12) 12
hydrogen-ion concentration (12) 12
models (12) 12
rat (12) 12
article (11) 11
biochemistry, general (11) 11
chemistry, multidisciplinary (11) 11
chemotherapy (11) 11
enzyme inhibitors - chemistry (11) 11
induction (11) 11
mechanism-based inhibition (11) 11
rats, wistar (11) 11
structure-activity relationship (11) 11
time-dependent changes (11) 11
clearance (10) 10
computer simulation (10) 10
cytochrome-p450 enzymes (10) 10
drug discovery (10) 10
pharmacodynamics (10) 10
young adult (10) 10
chromatography, liquid (9) 9
delayed-action preparations (9) 9
identification (9) 9
inhibitory concentration 50 (9) 9
ketoconazole (9) 9
microsomes (9) 9
midazolam (9) 9
model (9) 9
molecular structure (9) 9
protein binding (9) 9
time-dependent inactivation (9) 9
toxicity (9) 9
bioactivation (8) 8
biomedical engineering (8) 8
brain (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 06/2018, Volume 118, pp. 96 - 102
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 01/2013, Volume 53, Issue 1, pp. 14 - 20
Journal Article
CLINICAL INFECTIOUS DISEASES, ISSN 1058-4838, 12/2019, Volume 69, Issue Supplement_7, pp. 552 - 558
Cefiderocol, a novel parenteral siderophore cephalosporin, exhibits potent in vitro activity and in vivo efficacy against most gram-negative bacteria,... 
INFECTIOUS DISEASES | INFECTIONS | BACTERIA | SINGLE | SAFETY | S-649266 | linear pharmacokinetics | time-dependent cephalosporin | MICROBIOLOGY | IMMUNOLOGY | VITRO ANTIMICROBIAL ACTIVITY | PREDICTION | cefiderocol | dose adjustment | CEFEPIME | carbapenem resistance | AUGMENTED RENAL CLEARANCE | CRITICALLY-ILL PATIENTS | Supplement
Journal Article
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 11/2014, Volume 78, Issue 5, pp. 1005 - 1013
Aims Vatalanib is an oral anti‐angiogenesis agent that inhibits vascular endothelial growth factor receptor tyrosine kinases, which in patients showed auto... 
population pharmacokinetic model | autoinduction | time‐dependent clearance | vatalanib | Population pharmacokinetic model | Autoinduction | Time-dependent clearance | Vatalanib | INCREASED ANGIOGENESIS | RECEPTOR | ACUTE MYELOID-LEUKEMIA | IFOSFAMIDE METABOLISM | LIVER METASTASES | time-dependent clearance | CANCER-PATIENTS | TIME-DEPENDENT PHARMACOKINETICS | TYROSINE KINASE INHIBITOR | PHARMACOLOGY & PHARMACY | PHASE-I | ENDOTHELIAL GROWTH-FACTOR | Prospective Studies | Area Under Curve | Phthalazines - pharmacokinetics | Humans | Middle Aged | Pyridines - pharmacokinetics | Male | Metabolic Clearance Rate | Young Adult | Angiogenesis Inhibitors - administration & dosage | Pyridines - adverse effects | Time Factors | Computer Simulation | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Adult | Female | Angiogenesis Inhibitors - adverse effects | Myelodysplastic Syndromes - drug therapy | Pyridines - therapeutic use | Data Interpretation, Statistical | Myelodysplastic Syndromes - metabolism | Phthalazines - administration & dosage | Pyridines - administration & dosage | Angiogenesis Inhibitors - pharmacokinetics | Phthalazines - therapeutic use | Models, Biological | Aged | Phthalazines - adverse effects | Physiological aspects | Plants | Angiogenesis inhibitors | Endothelial growth factors | Phosphotransferases | Analysis | Index Medicus | Pharmacokinetics
Journal Article
Journal of Pharmacokinetics and Pharmacodynamics, ISSN 1567-567X, 10/2017, Volume 44, Issue 5, pp. 403 - 414
Journal Article
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 03/2019, Volume 130, pp. 137 - 146
This work aims to explore the unphysical assumptions associated with i) the homogeneity of the well mixed compartments of pharmacokinetics and ii) the... 
Heterogeneity | Unphysical assumptions | Fractal kinetics | Time dependent coefficient | Dissolution | Flip flop kinetics | SYSTEM | UNIVERSALLY UNRECOGNIZED ASSUMPTION | CLEARANCE | MODEL | RELEASE | BIOPHARMACEUTICAL CLASSIFICATION | SOLUBILITY | WEIBULL DISTRIBUTION | KINETICS | PHARMACOLOGY & PHARMACY | Monte Carlo method | Analysis | Index Medicus
Journal Article